Removal of MuRF1 Increases Muscle Mass in Nemaline Myopathy Models, but Does Not Provide Functional Benefits
Nemaline myopathy (NM) is characterized by skeletal muscle weakness and atrophy. No curative treatments exist for this debilitating disease. NM is caused by mutations in proteins involved in thin-filament function, turnover, and maintenance. Mutations in nebulin, encoded by NEB, are the most common...
Main Authors: | Johan Lindqvist, Justin Kolb, Josine de Winter, Paola Tonino, Zaynab Hourani, Siegfried Labeit, Coen Ottenheijm, Henk Granzier |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/15/8113 |
Similar Items
-
Pharmacological Inhibition of Myostatin in a Mouse Model of Typical Nemaline Myopathy Increases Muscle Size and Force
by: Johan Lindqvist, et al.
Published: (2023-10-01) -
Novel mutations in <it>NEB </it>cause abnormal nebulin expression and markedly impaired muscle force generation in severe nemaline myopathy
by: Lawlor Michael W, et al.
Published: (2011-06-01) -
Nemaline Myopathy: A Case Report
by: Adnan A. Mubaraki
Published: (2021-07-01) -
Nemaline Myopathy in Brazilian Patients: Molecular and Clinical Characterization
by: Juliana Gurgel-Giannetti, et al.
Published: (2022-10-01) -
Testing of therapies in a novel nebulin nemaline myopathy model demonstrate a lack of efficacy
by: Tamar E. Sztal, et al.
Published: (2018-05-01)